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ABSTRACT Labeled cDNA probes highly enriched for B-
cell-specific (B*-T) and T-suppressor-cell-specific (T,*-B) se-
quences were used to screen a set of genomic cosmid clones
spanning 230 kilobases of the murine immune response (I) re-
gion. With the B-cell derived probe, four I-region genes were
detectable (Ap, Eig, E.62, and Ea), as well as an additional(fifth) region of hybridization. The T-cell probe, prepared
from a putative I-J positive suppressor cell hybridoma, was
negative in a parallel experiment. A genomic fragment corre-
sponding to the new region of hybridization seen with the B-
cell cDNA probe identified a discrete mRNA species in RNA
blotting analysis that had a pattern of expression strikingly
similar to E. mRNA in a variety of lymphoid tumor lines. This
fragment was also used to isolate cDNA clones from a library
highly enriched (20-40 times) for B-cell-specific sequences (se-
lected cDNA cloning). DNA sequence analysis of one of these
cDNA clones indicates that this gene encodes the Aa molecule
of the d haplotype (Ad). These findings establish that the order
of the class II genes in the Ia complex is as follows: centromere-
A-Aa-Ep-EJ2-E&
The classical experiments of McDevitt and Benacerraf and
their co-workers first identified the major histocompatibility
complex as an important modulator of the mammalian re-
sponse to antigen (1). Differences between "high respond-
ers" and "low responders" to polypeptide antigens mapped
to the MHC region in the mouse and to its equivalent in guin-
ea pigs. The genes responsible for this modulation were
named immune response (Ir) genes. Subsequent genetic
analysis, coupled with sensitive cellular assays, localized the
genes controlling this phenomenon in the proliferating or
helper T-cell subset to the I region between the K and D loci
of the mouse H-2 complex (2, 3) and demonstrated that the
group of molecules encoded by this region, called the Ia mol-
ecules, are the principal determinants of high or low respon-
siveness (4, 5). In addition, a wide variety of cellular and
biochemical studies have demonstrated the importance of
the Ia complex in the recognition of antigen by certain T cells
(reviewed in ref. 6).
The I region has been divided by recombinational analysis
into five subregions: I-A, I-B, I-J, I-E, and I-C (7). There are
two well-defined Ia molecules, I-A and I-E, each with non-
covalently associated a and P chains (8). The A,, Ap, and Ep
chains are encoded in the I-A subregion and the Ea chain are
encoded in the I-E subregion (7-9). In mice, the I-A and I-E
molecules are characteristic of B lymphocytes and macro-
phages but not T lymphocytes. The I-J determinant, charac-
teristic of certain suppressor T cells, maps to the I-J subre-
gion (10, 11). No cell-surface markers have been assigned to
the I-B or I-C subregions.
Recently, 230 kilobases (kb) of the murine I region were
isolated from a cosmid library, prepared from BALB/c
strain DNA, using cross-hybridizing human probes and
chromosomal walking procedures (12, 13). Three of the four
known genes encoding Ia polypeptides were identified with-
in these clones (Au9, E,6, and Ea). In addition, an apparent
gene fragment, designated E82, was also found within this
region (12). Using cell-type-specific cDNA probes that rep-
resent a small subset ("'2%) of B- and T-cell gene expression
(ref. 14; unpublished observation), we screened the cosmid
clones for any additional genes that might be expressed in
lymphocytes. We found this approach to be a rapid and effi-
cient way of surveying large expanses of the chromosome,
and it should be of general utility in "saturating" an expanse
of cloned DNA for differentially expressed genes. In particu-
lar, we were able to localize and establish the orientation of
the Ad gene.
MATERIALS AND METHODS
Cell Lines and Culture Conditions. Bal 17, K46, L1OA,
X16C, and Bal 4 were obtained from J. Kim and R. Asofsky
(15, 16) and are of the H-2d haplotype. WEHI-231 was ob-
tained from L. Lanier and N. Warner. The Abelson pre-B-
cell lines 38B7 and 2043-1 (H-2d) were obtained from N. Ros-
enberg. The suppressor T-cell hybridoma 34S-704 was ob-
tained from M. Tanguichi (17). All lines were grown in RPMI
1640 medium containing glutamine/10% fetal bovine se-
rum/2-mercaptoethanol (50 aM) in 5% C02/95% air.
Cytoplasmic RNA Preparation. Cells were grown to a high
density (1-2 x 106 per ml), refreshed with new medium for
2-4 hr, chilled with phosphate-buffered saline, and cytoplas-
mic RNA was prepared as described (18). Poly(A)+ RNA
was made by selecting once over oligo(dT) cellulose.
Cell-Type-Specific Probes and Blot Hybridization. 32P-la-
beled cDNA was synthesized as described (19) from 1-5 pug
of template poly(A)+ RNA in 50 mM Tris HCl, pH 8.3/6mM
MgCl2/60 mM NaCl/1 mM dATP/1 mM dGTP/1 mM
dTTP/500 gCi of [a- 2P]dCTP (800 Ci/mmol; 1 Ci = 37
GBq) (6 ,uM final concentration)/30 tkM dCTP/oligo(dT) (10
pg/ml)/20 mM dithiothreitol/actinomycin D (100 ,g/ml) in
a 100-gl reaction mixture. Ten units of avian myoblastosis
virus reverse transcriptase (from J. Beard) was added per /Xg
of poly(A)+ RNA and incubated for 2 hr at 42°C. At the end
of this time, an equal volume of 0.2 M NaOH was added, and
the reaction was incubated at 70°C for 20 min to hydrolyze
the RNA. The mixture was cooled on ice, neutralized with 1
M HCl, and NaOAc (pH 6.5) was added to 0.2 M and Na-
Abbreviations: T,, suppressor T cell; kb, kilobase(s).
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DodSO4 was added to 0.1%. After warming to room tem-
perature, the labeled cDNA was excluded from G-SOF Seph-
adex in a Pasteur pipette column with a running buffer of 100
mM NaCl/50 mM Tris-HCl, pH 7.5/1 mM EDTA/0.02% Na-
DodSO4. Fifty micrograms of tRNA was added as carrier
and the cDNA was precipitated in a silanized Eppendorf
tube (1.5 ml). The precipitate was washed once with 70%
ethanol, dried, and resuspended in water. The labeled
cDNAs (1.8 x 108 cpm/,ug) were allowed to decay for 2
weeks to fragment the material.
Hybridization reactions were carried out in sealed glass
capillaries (20 Al, silanized) in 0.5 M phosphate buffer/5 mM
EDTA/0.1% NaDodSO4 with the relevant mRNA at 1-1.5
mg/ml. Sheared mouse genomic DNA was also included (1.2
mg/ml; 20 pg per reaction mixture) to remove repeated se-
quences. After boiling for 60 sec to denature the genomic
DNA and disaggregate the RNA, the reactions were incubat-
ed for 16-20 hr at 68°C. This achieved a Cot value of 1500 for
the RNA and 10 for the DNA. Hydroxyapatite chromatogra-
phy was then used to fractionate the material in 0.12 M phos-
phate buffer/0.1% NaDodSO4 at 60°C; 91.5% of the B-cell
cDNA and 90.5% of the suppressor T-cell (Ts) cDNA bound
to the column (double-stranded fraction). The single-strand-
ed fraction was concentrated with sec-butanol, extracted
with CHC13 to remove the butanol, and then aerated to re-
move the CHCl3. It was then hybridized to Southern blots as
described (20). Washing was with 5 x SSPE for 1 hr at 65°C
and then 1x SSPE for 2 hr at 65°C.
Selected cDNA Cloning. The first cDNA strand was syn-
thesized and hybridized as described above for the probe ex-
cept that 70 mM KCI was used instead of NaCl and 1 mM
dCTP was used with only trace amounts of 32P-dCTP (to give
a first strand specific activity of 105 cpm/tg). After hy-
droxyapatite selection, the bulk of the single-stranded mate-
rial was concentrated with sec-butanol and excluded from
Sephadex G-50F (Pasteur pipette column) to remove the
phosphate buffer (which would inhibit precipitation). Fifty
micrograms of tRNA carrier was added and the single-
stranded cDNA was precipitated. Because this cold cDNA is
somewhat longer, the reactions were closer to completion
with 95% and 96% of the B-cell cDNA hybridizing to the T-
cell (Bal 4) mRNA in two separate experiments. The select-
ed cDNA was resuspended in water and made double-
stranded with DNA polymerase I under standard conditions
with at least 75% of the first strand mass synthesized (the
second strand specific activity was 106 cpm/pg). The dou-
ble-stranded material was diluted with 4 vol of nuclease S1
buffer, and the hairpin loop was cleaved with nuclease S1.
The extent of nuclease S1 cleavage was analyzed on a dena-
turing gel. G-C tailing with terminal transferase (P-L Bio-
chemicals) was as described (21) with the modification that
the nucleotide concentration was varied to control the rate of
the tailing reaction. In this case, 100 ,tM dCTP was neces-
sary for a 1.5-min reaction at 370C, yielding 20-30 cytidines
per 3' end (average). With other lots of terminal transferase,
as little as 2 ,uM dCTP was necessary.
RESULTS
Screening I-Region Genomic Clones with B-Cell and T-Cell
Derived cDNA Probes. B- and T-cell tumors reproducibly dif-
fer by -2% (1.7-2.4%) of their cytoplasmic poly(A)+ RNA
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FIG. 1. Hybridization of B*-T and T*-B
cDNA probes to I-region genomic clones. (A) I-
region genomic clones, relevant restriction
sites, and the location of the Ap, Ep, E,02, Ea
genes (12, 13). (B) Ethidium bromide-staining
pattern of the cosmid clones shown in A.
Lanes: a, cosmid 34.2; b, 41.1; c, size markers
(the sizes, in kb are 48, 33, 23, 21.6, 19.7, 16.5,
15.5, 13.3, 10.6, 9.8, 8.6, 8.4, 7.7, 6.6, 5.9, 5.6,
4.8, 4.5, 3.6, 2.5, 2.4, and 2.2); d, 24.2; e, 8.4; f,
17.2;g,54.2;h,7.1;andi,61.1. Lanesa,b,d,e,
and f are EcoRI digests; lanes g, h, and i are
Kpn/Sma digests. (C) Hybridization of the
clones to a B*-T probe (Bal 17/Bal 4). The faint
background seen in the marker lane (c) and oth-
er lanes seems due to nonspecific trapping of
labeled cDNA by high molecular weight DNAs.
Lane designations are as in B. (D) Hybridiza-
tion of the I-region clones to a T*-B probe (34S-
504-L1OA). Lane designations are as in B.
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(mRNA) mass (16). Consequently, labeled cDNA probes
corresponding to these differences can be enriched up to 50-
fold and used to detect even very rare sequences in clone-
screening experiments. We screened Southern blots of the I-
region cosmid clones with two different selected cDNA
probes, a B-cell-specific or a B*-T probe (B-cell cDNA mi-
nus T-cell mRNA) and a Ts probe made by subtracting the
cDNA of a Ts hybridoma with B-cell mRNA (T*'-B). Fig. 1A
shows the I-region cosmids, the position of the identified
genes, and the relevant restriction maps (from refs. 12 and
13). Each of these clones were digested with EcoRI, or with
Kpn I and Sma I, electrophoresed through an agarose gel
and blotted onto nitrocellulose filters in duplicate. The P-
labeled cDNAs were synthesized to high specific activity
(1.8 x 108 cpm/,ug), and allowed to decay for 2 weeks to
promote strand scissions (1-2 per molecule). This fragmenta-
tion allows shared domains or repeated sequences to be re-
moved while cell-type-specific regions of a given mRNA
would still be present. The B-cell line used was the B-cell
lymphoma, Bal 17, which is typical of B-cell stage tumor
lines (IgM+ IgD+ Ia') (15). The T-cell mRNA used to sub-
tract it was isolated from Bal 4, which is a (Thy 1+ Lytl-
Lyt2+ TL+) thymoma (16). The Ts line is a putative I-J+,
BW5147 fusion with keyhole limpet hemocyanin-specific
suppressor activity (17) and its cDNA was subtracted with
mRNA from another B lymphoma, L1OA (15).
In addition to being subtracted once with mRNA, the
cDNAs were also hybridized with total genomic DNA to a
repetitive Cot of 10 in the same reaction. This removes highly
repeated sequences that might give false positives in the
screen. Fig. 1B shows representative ethidium bromide-
stained restriction fragments of the cosmid clones; Fig. 1C
shows the hybridization with the B-cell probe (B*-T), and
Fig. ID shows the results with the T-cell probe (T*-B). With
the B-cell probe, one can clearly see all of the previously
identified (ref. 12) gene regions hybridizing; namely A9, EO,
E82, and Ea. In addition, a fifth region of hybridization, la-
beled "X," can be seen in Fig. 1C (lanes b and d). From the
restriction map, we can localize the X region to the area be-
tween Ap and Es (see Fig. 1A). By contrast, in a parallel
experiment, the T,-cell probe was completely negative, with
no detectable hybridization above background either in the
putative I-J subregion (at the 3' end of the Ep gene) or any-
where in the clones surveyed. Since the Ia genes appear to
represent -0.01% of the mRNA of B-cell lines (unpublished
results) and are clearly detectable in Fig. 1C, we estimate
that the sensitivity of the T.-B probe screen may be as low as
0.001-0.002% or 2-5 mRNAs per cell. Kronenberg et al. (22)
have also been unable to detect an I-J mRNA using labeled
genomic fragments to probe a variety of Ts hybridomas.
RNA Blot Analysis. A 4.7-kb fragment from the genomic
clone 24.2 (Fig. 1A, "probe"; probe 2 in ref. 12) contains
most of the X region and was used in RNA blot analyses of
lymphoid tumor mRNAs (Fig. 2). These data show that the
X region encodes a discrete mRNA species of 1.25 kb and
that the mRNA seems coordinately expressed with Ea,^. Both
molecules are strikingly B-cell-stage specific in their lack of
expression in either the two plasma cells or pre-B-cell lines.
Also interesting is the decrease in these two messages in
WEHI-231 cells after 24 hr of LPS stimulation, versus the
relatively unchanged expression of the Cgu gene in these
cells.
Selected cDNA Cloning. Probe 2 was used to isolate a near-
ly full-length cDNA clone from a library enriched from B-
cell-specific (B-T) sequences. The procedure for construct-
ing this library is shown in Fig. 3. The cDNA was synthe-
sized from Bal 17 (B) poly(A)+ RNA in the presence of
actinomycin D (to suppress foldback loop formation), then
hybridized to a 10-fold excess of T-cell mRNA (Bal 4) and
selected on hydroxyapatite. The single-stranded fraction was
made double-stranded with DNA polymerase I, trimmed
with nuclease S1 and cloned into the Pst site of pBR322 by
B-Cell Stage Tumors Plasma Cell
W231 /M
















FIG. 2. Hybridization of probe X to a discrete mRNA species in particular B-cell tumors. A Ctu probe (23), an E", probe (unpublished data)
and the X genomic probe (Fig. LA) were nick-translated (24) to a specific activity of 3-6 x 10' cpm/pg and hybridized to RNA blots (25) of
various lymphoid tumor line poly(A)+ cytoplasmic RNAs. The RNA blots were prepared using methylmercury-agarose gel electrophoresis and
APT paper (26). Size markers are in kb.
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G-C tailing (27). The transformation efficiency was high
(50,000-200,000 clones per gg of insert) and the average in-
sert size was 500 base pairs. Less than 5% of the clones are
capable of hybridizing to labeled T-cell cDNA. We have also
made a selected cDNA library of T-cell-specific sequences
and T. Sargent and his colleagues have made a Xenopus-
stage-specific library (28). In cases where small differences
exist between mRNA populations, these selected libraries
can be an important source of clones of cell-type-specific
cDNAs. In the case examined here, probe X hybridized with
46 colonies out of -9000 total, whereas an unselected library
consisting of the same number of clones would be expected
to yield between 1 and 2 positives. Therefore, we estimate a
20- to 40-fold enrichment for the sequences of interest.
Sequence of the Ad cDNA Clone. One of the largest cDNA
clones, pBall7 105, with an insert size of 956 nucleotides,
was sequenced by the procedure of Maxam and Gilbert (29).
An open reading frame extends for 768 nucleotides, begin-
ning with a methionine initiator codon, including a probable
leader peptide, and terminating with a TGA stop codon. By
comparing this sequence to that determined for other class II
molecules, we were able to identify this gene as encoding Ad
(30, 31). There is perfect homology (10/10 amino acid resi-
dues) between the amino acid residues predicted by this
clone to that established for Ad by protein sequence analysis
(30). Furthermore, the coding region sequence in pBall7 105
is identical to that of the Ad cDNA clone described by Ben-
oist et al. (31).
The Ia Gene Cluster. The data presented in this paper now
allow us to position all of the known Ia genes within the I
SELECTED cDNA CLONING
WITH ACTINOMYCIN A mRNA ...*WITHOUT ACTINOMYCIN
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FIG. 3. Selected cDNA cloning. cDNA was synthesized in the
presence of actinomycin to suppress hairpin-loop formation. It is
postulated that a small foldback loop is synthesized and serves as a
primer for DNA polymerase I but it is possible that this is a very
transient structure. The remainder of the procedure is similar to
those in the literature (see Materials and Methods).




-3' 3' - 5'
10 kb
FIG. 4. The organization of the Ia gene cluster. Partial sequence
analysis of the genomic A,, clone established its transcriptional ori-
entation within the Ia complex. This sequence was determined from
the EcoRI site of the X genomic subclone (Fig. 1A) located in the 3'-
untranslated region of the A' gene and from a Pst I site in the first
external domain. The small box to the left of Ea, is E02, a possible
pseudogene (12).
region of the MHC (Fig. 4). Recombination analyses using a
peptide map assay had previously suggested an order of A,-
A,9-E-Ea (32), but the data presented here clearly indicate an
order of Ap3-Ao-El-EE. The difference cannot be explained by
postulating an inversion in gene order between the k and d
strains because genomic clones from the k haplotype have
been shown to have an identical arrangement (13). Partial
genomic sequence analysis of A, has determined the orienta-
tion of the gene (Fig. 4), showing that both of the a genes are
transcribed in the same direction, opposite to that of the /3
genes. This suggests that the putative ancestral gene com-
plex (/3a) was duplicated as a unit; that is, O3a -* /3a/3a.
DISCUSSION
Selected Probes and Libraries. The data presented in this
paper demonstrate the utility of using selected probes to
screen specific subsets of the genome. A selected cDNA
probe screening, such as we have described here, may be the
method of choice for identifying all of the cell-type-specific
genes in a given genomic subregion. The I region is particu-
larly interesting in this regard as there are a number of func-
tions and molecules mapped to this region for which genes
have not yet been isolated (33-35). Additional genomic
clones, especially toward the K region proximal to An (Fig.
LA), and probe combinations other than those used here,
may be fruitful in detecting these genes. This combination of
a cell-type selection with a genomic-subregion selection can
also be extended to libraries derived from mini-chromosomal
DNA or specific chromosomes. In addition, we have found
selected cDNA libraries to be an important resource for de-
riving cell-type-specific clones because it considerably de-
creases the number of clones to be screened.
One major caveat in using cDNA selection is the possible
loss of sequences of interest because of the presence of ho-
mologous mRNA in the absorbing population due to aber-
rant or lower level expression, translational regulation, or
the differential expression of members of a related gene fam-
ily. In fact, on examination with a partial Ap3 cDNA probe(36) we have found that the mRNA from the T-cell line Bal 4
used here for absorption contains small but detectable quan-
tities of A,3 mRNA (unpublished observation). Since An is
clearly detectable on the screen of the I region clones (Fig.
1C) it would seem that the 10:1 mass excess of Bal 4 mRNA
to Bal 17 cDNA was not sufficient to obscure the signal seen
in Fig. 1B. This appears to be the exception rather than the
rule, however, since most T cells do not express An and in
general we find that 6/7 B-cell markers (K, X, Al, Aa, E,3, Ea,but not ,t) and 1/1 T-cell markers (Thy 1; ref. 37) are in the
relevant absorbed B*-T and T*-B cDNA probes, respective-
ly. Previously, Mather et al. (38) obtained a J-chain gene iso-
late using a cDNA subtraction based on protein expression
data. Thus, in general it seems appropriate to use subtracted
probes to screen for a wide variety of different genes.
Identification of A.. We have used a B-cell-specific probe
to screen directly genomic clones and to isolate the class II
MHC gene for A.. In the course of this work we have shown
Immunology: Davis et aL
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that Ad maps between A,8 and Ed, in contrast to the gene
order predicted from previous work (32). The B-cell-specific
probe was sensitive enough to screen, in addition, each of
the previously identified class II genes (AO, EO, E2, E.). The
screen depends on the observation that most murine T-cell
lymphomas that we have examined (unpublished observa-
tions) do not actively transcribe the I-A or I-E locus.
Using a similar approach, a T,-specific probe was found
not to hybridize with the I region cosmids. Such a result
could be explained if I-J gene products were quite closely
related to products expressed by B lymphomas, if I-J were a
transcriptional variant of such a product, or if I-J were en-
coded outside the region probed. The failure to find I-J in
these genomic clones is consistent with other reported work
(22).
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